Resultados de la búsqueda 621-630 of 10551 for Transient ischaemic attack

  1. Neurología - Ensayos clínicos - Mayo Clinic

    A Study Of Paired-Vagus Nerve Stimulation On Functional Connectivity In Ischemic Stroke. Rochester, Minn. The purpose of this study is to delineate the ...

  2. Ensayos clínicos - Neurología

    ... ischemic stroke or high risk TIA (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) improves ...

  3. Cirugía - Ensayos clínicos - Mayo Clinic

    A Study Of Vagus Nerve Stimulation (VNS) With Mobility Training For Gait Recovery After Chronic Ischemic Stroke. Rochester, Minn. The purpose of this study ...

  4. Neurología - Ensayos clínicos - Mayo Clinic

    A Study Of Paired-Vagus Nerve Stimulation On Functional Connectivity In Ischemic Stroke. Rochester, Minn. The purpose of this study is to delineate the ...

  5. Neurología - Ensayos clínicos - Mayo Clinic

    A Study Of Paired-Vagus Nerve Stimulation On Functional Connectivity In Ischemic Stroke. Rochester, Minn. The purpose of this study is to delineate the ...

  6. Cirugía - Ensayos clínicos - Mayo Clinic

    A Study Of Vagus Nerve Stimulation (VNS) With Mobility Training For Gait Recovery After Chronic Ischemic Stroke. Rochester, Minn. The purpose of this study ...

  7. Ensayos clínicos - Neurología

    ... ischemic stroke or high risk TIA (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) improves ...

  8. Medicina Física y Rehabilitación - Ensayos clínicos - Mayo Clinic

    A Study Of Vagus Nerve Stimulation (VNS) With Mobility Training For Gait Recovery After Chronic Ischemic Stroke. Rochester, Minn. The purpose of this study ...

  9. Ensayos clínicos - Medicina pulmonar

    ... ischemic stroke or high risk TIA (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) improves ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...